🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cerebellar Deep Brain Stimulation for the Treatment of Ataxia

RecruitingNAAges 20 Years - 70 YearsAllUniversity Health Network, Toronto
NCT07427563 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Abnormal gait is often associated with immobility and falls, which in turn lead to loss of functional independence and death. While gait disorders may arise from many different etiologies, dysfunction of the cerebellum (a part of the brain with the function of coordination of movement) leading to gait disorders results in distinct features. Gait ataxia is a specific type of neurological gait disorder and is defined as the presence of abnormal, uncoordinated movements associated with gait. To date, there are limited treatments for ataxia and/or gait disorders. Deep brain stimulation (DBS) is a neurosurgical tool that has been widely used for over twenty years, mainly to treat Parkinson's disease, dystonia, and essential tremor. In this study, we aim to implant DBS in patients with ataxia and/or gait disorder in the cerebellum area, and electrically stimulate them in a titratable and ultim

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Female or Male patients between age 20-70 2. Diagnosis of primary ataxia (inclusive of congenital and hereditary subtypes without other neurological compromise) 3. Head CT scan and cerebral MRI without any structural contraindications for safe DBS 4. Patient able to give written consent 5. Able to comply with all testing, follow-ups and study appointments and protocols Exclusion Criteria: 1. Active neurologic disease including but not limited to epilepsy and certain brain tumors 2. Secondary ataxia (such as due to stroke, medication, autoimmune disease, ischemia, tumor, or other lesion) 3. Any contraindication to MRI scanning 4. Likely to relocate or move during the study's one-year duration 5. Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions that will result in significant risk from a surgical procedure.
💊

What it tests

  • Deep Brain Stimulation
📍

Where

1 site
Toronto Western Hospital
Toronto, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy